- Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)2014 | Second Faculty of Medicine
- Long-Term Efficacy and Safety of Aerosolized Tobramycin 300 mg/4 ml in Cystic Fibrosis2014 | Second Faculty of Medicine